OBIO
Orchestra BioMed Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.08
+5.19%Sep 16, 2026, 12:30 UTC
Orchestra BioMed announced that its investigational AVIM Therapy will be featured in two sessions at HRX Live 2026, the Heart Rhythm Society's annual meeting in Atlanta, Georgia on September 18-20, 2026.
Source:Sep 15, 2026, 12:30 UTC
Haemonetics Corporation acquired Vivasure Medical Limited, with Orchestra BioMed receiving a $6.1 million milestone payment on September 14, 2026 as part of the deal.
Source:Aug 10, 2026, 22:56 UTC
Orchestra BioMed Holdings, Inc. reported a second-quarter loss of $0.38 per share, missing the Zacks Consensus Estimate of a loss of $0.35.
Source: